2019 BC CANCER RESEARCH REPORT Message from the Senior Executive Director of Research, Table of Contents Dr
Total Page:16
File Type:pdf, Size:1020Kb
2019 BC CANCER RESEARCH REPORT Message from the Senior Executive Director of Research, Table of Contents Dr. François Bénard 3 Message from the Senior Executive Director of Research, Dr. François Bénard At cancer research centres across Canada, 2019 marked the launch of the new Marathon of Hope Cancer Centres 4 Message from BC Cancer Foundation President and CEO, Sarah Roth Network (MOHCCN) through the Terry Fox Research Institute (TFRI), with support from the Government of 5 2019 Fast facts Canada. The MOHCCN will bring together our national 6 Awards and funding cancer centres to focus collective effort towards new precision medicine strategies for patients utilizing 14 Celebrating 20 years of Canada’s Michael Smith Genome Sciences Centre at BC Cancer genomic approaches applied for Canadians. This will mean sequencing and comprehensive genomic profiling 16 New recruits in 2019 for over 15,000 Canadians across the country in the 16 Food for thought: Dr. Rachel Murphy dissects diet and disease next five years. BC Cancer is proud to be one of the first centres piloting the MOHCCN, along with cancer centres 17 Down to the roots: Dr. Ly Vu looks for leads in acute myeloid leukemia in Montreal and Toronto. 18 Service spotlight: the graduate student and post-doctorate society at BC Cancer The new five-year Strategic Plan for BC Cancer Research Our 2019 report showcases how BC Cancer continues to was also implemented in July of 2019, with approval by 19 Service spotlight: BC Cancer Libraries and Cancer Information Centres be internationally recognized for our excellence in cancer the Provincial Health Services Authority (PHSA) Research Board. The ultimate goal for the plan is to strengthen our 20 Dr. Leah Lambert pushes to improve the circle of care research and its integrated model of cancer planning and care. While our researchers and trainees continue to research capabilities and align our strategies with the 22 Medical resident spotlight: Dr. Erica Tsang searches for solutions for pancreatic cancer receive a remarkable number of awards and publish their BC Cancer Foundation, PHSA, Terry Fox Research Institute, work in the world’s most prestigious scientific journals, regional health authorities, the University of British 24 Scientist spotlight: 2019 highlights of distinguished scientist Dr. Connie Eaves we are reminded every day that our research is not a pure Columbia (UBC) and other partner universities, including Simon Fraser University (SFU), University of Victoria (UVic) 26 Outstanding trainee publications 2019 academic exercise. We do this for our patients, friends and families whose lives are affected every day by cancer. and the University of Northern British Columbia (UNBC). 27 Biology and genetics Our research has purpose and we intend to make sure it This new plan for research provides clear direction that delivers a positive impact for everyone affected by cancer. improves our ability to generate knowledge, enhance 34 Health economics and cancer control the impact of our research and support innovation in Many of the groundbreaking research discoveries were clinical care. 35 Screening and diagnosis made possible thanks to Canada’s Michael Smith Genome Sciences Centre (GSC) at BC Cancer, which celebrated While there is still much work ahead of us at BC Cancer, 38 Treatment its 20th anniversary in November. In a tribute to this we are optimistic for the future as we continue to be a global leader in cancer care and research and every single 46 Cancer immunology and immunotherapy inspiring milestone, our 2019 research report focuses on genomics and the inspiring success of the GSC. Over the day we are reminded that our work is driven by our vision 50 Personalized OncoGenomics past two decades, the GSC has participated in thousands of a world free of cancer. of national and international collaborations and produced DNA sequence equivalent to approximately 900,000 human genomes. Globally, we have entered a new era On the cover: of precision medicine through the power of cancer Genome Sciences Centre Head of Laboratory Operations, Paul Lythgo with a portion of the GSC computer cluster at the GSC's Echelon technology platform. With 30,000+ hyper-threaded cores, 20+ PetaBytes of storage and 24 genomics research which continues to improve outcomes deep learning GPU devices, the GSC is home to some of Canada's largest computation infrastructure, used almost for patients through the identification of new approaches entirely for the storage and analysis of genomic data. Last year alone, the GSC sequenced 391,012,881,130,938 for cancer diagnostic and treatment strategies. bases of DNA, bringing its total to more than 2.74 petabases (2,740,000,000,000,000)—roughly equivalent to the number of base-pairs in nearly 900,000 human genomes. 2 BC CANCER 2019 RESEARCH REPORT BC CANCER 2019 RESEARCH REPORT 3 Message from BC Cancer Foundation President & CEO, Sarah Roth Fast Facts As I reflect on 2019 at the BC Cancer Foundation, I am excited by the outstanding research achievements and innovative projects at BC Cancer 15 that inspire our donors and advance researchers named among the 337 8 cancer care in B.C. As BC Cancer’s 302 world’s most active patents fundraising partner, we are proud to Researchers Highly Cited clinical trials filed support the extraordinary work that including clinical investigators Researchers happens across BC Cancer’s vast research enterprise. Many of the initiatives that take place at BC Cancer’s research centres are fueled by our generous community 34,341 556 total cumulative 17 of 95,000 donors who see the journal subject enrollment patents impact of innovation. This includes 612 articles in clinical trials issued the ground-breaking work underway Trainees in the area of genomics. Photo credit: BC Cancer Foundation. Since its inception, the BC Cancer Genomics represents a paradigm As your partner, the BC Cancer Foundation has been a major funder shift, ensuring the health of our Foundation is motivated by our of the Genome Sciences Centre. children and grandchildren for years united vision of a world free from 11 Over the past 20 years, the GSC team 655 active 37 to come. cancer. Together, we won’t stop has brought patients and families total spin-o active advancing life-saving research and, hope through advancements in Our donors are also enabling publications companies licenses ultimately, changing outcomes for all technology and scientific and clinical clinicians and scientists to push the (2 new) British Columbians. collaborations. Genomics is now a envelope, driving innovation across global movement and BC Cancer is borders. The BC Cancer Foundation a leader—there is no other facility in has partnered with the Terry Fox Other 2% Canada like the GSC. Research Institute and other large Infrastructure awards 8% % cancer centres and funding partners Salary awards 4% 9 1 Last November, at our annual under the Marathon of Hope Cancer G y Inspiration Gala, our community r o t Centres Network, a pan-Canadian v s rallied together to raise an incredible e u initiative to accelerate the adoption r d $3 million to advance genomics n n m I of precision medicine. This is an e research. Funds raised will allow n t example of BC Cancer expertise BC Cancer’s brilliant oncologists, 3 Op co-leading a powerful collective on 8 e bioinformaticians, pathologists and % ra tin a national stage to change outcomes g gra s 86% scientists to get closer to achieving nt By Award Type for all Canadians facing cancer. our mission to break down cancer % 43 for the more than 27,000 British ofit By Sector Non-pr Columbians diagnosed each year. Funding Total Grants Awarded: $70 million 4 BC CANCER 2019 RESEARCH REPORT BC CANCER 2019 RESEARCH REPORT 5 Operating grants 86% Awards & Funding 2019 January clinical research as they transition from training programs • Dr. Arman Rahmim was awarded $631,124 over four CIHR Fall 2018 Special Operating Grants to careers as independent investigators. Dr. Ryan Morin years to study the quantitative PSMA targeted imaging of Dr. Rachel Murphy was awarded a CIHR Dr. Shoukat Dedhar, distinguished scientist has been studying the genetic nature of lymphoid cancers prostate cancer patients. Operating Grant of $100,000 to lead a with Integrative Oncology, received the using genomic methods for more than a decade. During • Dr. Yuzhuo Wang was awarded $956,250 over five years study aiming to identify risk factors—other University of British Columbia Killam his doctoral training at UBC and BC Cancer, he pioneered to investigate the function and therapeutic potential of than smoking—that may increase the risk Research Prize in recognition of his the use of transcriptome and whole genome sequencing to SUV420H2 in neuroendocrine prostate cancer. of developing lung cancer. The study will use outstanding research and scholarly contri- identify driver mutations in non-Hodgkin lymphomas. Over • Dr. Julian Lum was awarded a $1.08 million to study the large datasets of health information about Canadians from butions. Dr. Dedhar has pioneered a large body of work in the course of his training, he published a series of papers role of sugar in regulating T cell responses and derive new across the country, including the BC Generations Project the cellular and molecular biology of cell-extracellular matrix describing some of the most common genetic features avenues to enhance T cell immunotherapy. based out of BC Cancer, which includes a cohort of nearly interactions, including significant insights into the roles of of diffuse large B-cell lymphoma (DLBCL) and follicular 30,000 B.C. participants who have volunteered their health tumour microenvironments and hypoxic stress as driving lymphomas including EZH2, KMT2D, CREBBP and MEF2B. • Dr. Kuo-Shyan Lin was awarded $772,650 over five years information and biological samples to help researchers learn forces for metastatic potential in cancers.